Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin in Mild to Moderate COVID-19
NCT05076253Phase 2Completed
- Sponsor
- Vajira Hospital
- Start
- Sep 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ivermectin in coronavirus disease 2019 (COVID-19), sponsored by Vajira Hospital. Started Sep 2021; status: completed.
02
Drugs
ivermectin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05076253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05076253.